Poulsbo firm gets FDA OK to treat common eye problem
Abstract
He has good reason to be happy – his company, Lumithera in Poulsbo, a family-owned medical device company, recently received word that the Food and Drug Administration has approved their new product, Valeda, a non-invasive treatment for degenerative eye disease.
“The target we’re going after, age-related macular degeneration, is the largest cause of vision loss in adults over the age of 65,” said Tedford, who has a doctorate in pharmacology. “There aren’t a lot of alternatives for these patients, and over years they’ll lose their vision slowly, and it can be devastating.”
Read More on kitsapdailynews.com or download the PDF.
